Business
BELR Subsidiary 4BiddenKnowledge to Bring the 4BK BioKey™ Educational Breath Biomarker Wellness Device to Market
BELR Subsidiary 4BiddenKnowledge to Bring the 4BK BioKey™ Educational Breath Biomarker Wellness Device to Market.
About this update from Bell Rose Capital Inc.
[{"type":"text","content":"BOCA RATON, FL, UNITED STATES, May 19, 2026 /EINPresswire.com/ -- Bell Rose Capital Inc. (OTCID: BELR) today announced that its wholly owned subsidiary, 4BiddenKnowledge Inc., plans to bring its patent-pending 4BK BioKey™ educational breath biomarker wellness device to the consumer pre-order market, with initial fulfillment targeted for approximately six months after order placement.The 4BK BioKey™, branded as “The Breath of Knowledge,” is being developed as a handheld consumer breathomics platform designed to provide users with non-invasive wellness insights through breath-based biomarker education. The device is intended to help consumers better understand metabolic trends, breath-based wellness markers, lifestyle patterns, and personal health optimization signals through a simple breath test.BioKey is being positioned as an educational wellness device and is not intended to diagnose, treat, cure, mitigate, or prevent any disease or medical condition. The device is not intended to replace physician guidance, clinical testing, laboratory diagnostics, or any authorized medical device.BioKey is being positioned as an educational wellness device and is not intended to diagnose, treat, cure, mitigate, or prevent any disease or medical condition. The device is not intended to replace physician guidance, clinical testing, laboratory diagnostics, or any authorized medical device.Human breath contains more than 1,000 volatile organic compounds, commonly known as VOCs, that may reflect metabolic and physiological processes. The BioKey platform is being designed to analyze 60+ breath biomarkers and biomarker signatures using a modular sensor architecture that includes metal oxide semiconductor sensors, non-dispersive infrared CO₂ sensing, and electrochemical sensing platforms. The company believes this architecture may provide consumers with a new category of real-time wellness education, metabolic awareness, and personalized lifestyle feedback.“BioKey is designed to empower people with a new level of self-awareness,” said Billy Carson, inventor of BioKey and CEO of Bell Rose Capital Inc. “This is not about replacing doctors or medical testing. This is about helping individuals understand their own bodies more deeply, using breath as a non-invasive window into wellness, lifestyle patterns, metabolic trends, and personal optimization.”The...